Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice

British Journal of Pharmacology

Volumn 117, Issue 7, 1996, Pages 1579-1585

  Noda, Yukihiro ^a   Yamada, Kiyofumi ^a   Komori, Yumiko ^b   Sugihara, Hisayoshi ^b   Furukawa, Hiroshi ^b   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Behavioural changes in mice; Nitric oxide; Nitric oxide synthase; Phencyclidine; Sensitization; Tolerance

Indexed keywords

ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENCYCLIDINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; ENZYME ACTIVITY; HEAD MOVEMENT; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SENSITIZATION; SNIFFING; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029919094     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15324.x     Document Type: Article

References (48)

1. BALSTER, R.L. & CHAIT, L.D. (1976). The behavioural pharmacology of phencyclidine. Clin. Toxicol., 9, 513-528.
2. BÖHME, G.A., BON, C., LEMAIRE, M., REIBAUD, M., PIOT, O., STUTZMANN, J.M., DOBLE, A. & BLANCHARD, J.C. (1993). Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc. Natl. Acad. Sci. U.S.A., 90, 9191-9194.
3. BREDT, D.S., GLATT, C.E., HWANG, P.M., FOTUHI, M., DAWSON, T.M. & SNYDER, S.H. (1991). Nitric oxide synthase protein and mRNA are discretely localized in neuronal population of the mammalian CNS together with NADPH diaphorase. Neuron, 7, 615-624.
4. BREDT, D.S. & SNYDER, S.H. (1989). Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A., 86, 9030-9033.
5. CHAIT, L.D. & BALSTER, R.L. (1978). The effect of acute and chronic phencyclidine on schedule-controlled behaviour in the squirrel monkey. J. Pharmacol. Exp. Ther., 204, 77-87.
6. CHAPMAN, P.F., ATKINS, C.M., ALLEN, M.T., HALEY, J.E. & STEINMET, J.E. (1992). Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport, 3, 567-570.
7. COLLIER, J. & VALLANCE, P. (1989). Second messenger role for NO widens to nervous and immunesystems. Trends Pharmacol. Sci., 10, 427-431.
8. DAWSON, T.M., BREDT, D.S., FOTUHI, M., HWANG, P.M. & SNYDER, S.H. (1991). Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. U.S.A., 88, 7797-7801.
9. DUDEK, R.R., CONFORTO, A., PINTO, V., WILDHIRT, S. & SUZUKI, H. (1995). Inhibition of endothelial nitric oxide synthase by cytochrome P-450 reductase inhibitors. Proc. Soc. Exp. Biol. Med., 209, 60-64.
10. G-nitroarginine in brain in vitro and in vivo. Biochem. Biophys. Res. Commun., 176, 1136-1141.
11. FÖSTERMANN, U , GORSKY, L.D., POLLOCK, J.S., SCHMIDT, H.H.H.K., HELLER, M. & MURAD, F. (1990). Regional distribution of EDRF/NO-synthesizing enzymes in rat brain. Biochem. Biophys. Res. Commun., 168, 727-732.
12. GARTHWAITE, J., CHARLE, S.L. & CHESS-WILLIAMS, R. (1988). Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 336, 385-388.
13. GORECKI, D., GENG, Y., THOMAS, K., HUNT, S.P., BARNARD, E.A. & BARNARD, P.J. (1991). Expression of the dystrophin gene in mouse and rat brain. Neuroreport, 2, 773-776.
14. GUEVARA-GUZMAN, R., EMSON, P.C. & KENDRICK, K.M. (1994). Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem., 62, 807-810.
15. HECKER, M., MITCHELL, J.A., HARRIS, H.J., KATSURA, THIEMERMANN, M.C. & VANE, J.R. (1990). Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem. Biophys. Res. Commun., 167, 1037-1043.
16. HIRAMATSU, M., NABESHIMA, T. & KAMEYAMA, T. (1984). Effects of enkephalin analogs, morphine and naloxone on the behavioural responses of phencyclidine in mice. Res. Commun. Subst. Abuse, 5, 161-173.
17. HÖLSCHER, C. & ROSE, S.P.R. (1993). Inhibiting synthesis of the putative retrograde messenger nitric oxide results in amnesia in a passive avoidance task in the chick. Brain Res., 619, 189-194.
18. HOLSZTYNSKA, E.J. & DOMINO, E.F. (1983). New metabolites of phencyclidine (PCP): Evidence for involvement of multiple forms of cytochrome P-450 in PCP biotransformation. In Phencyclidine and Related Arylcyclohexylamines: Present and Future Applications, ed. Kamenka, J.M., Domino, E.F. & Geneste, P. pp. 215-237. Ann Arbor, MI: NPP Books.
19. ITZHAK, Y. (1994). Blockade of sensitization to the toxic effects of cocaine in mice by nitric oxide synthase inhibitors. Pharmacol. Toxicol., 74, 162-166.
20. KHANNA, J.K., MORATO, G.S., SHAH, G., CHAU, A. & KALANT, H. (1993). Inhibition of nitric oxide synthesis impairs rapid tolerance to ethanol. Brain. Res. Bull., 32, 43-47.
21. KITAICHI, K., YAMADA, K., YONEDA, Y., OGITA, K., HASEGAWA, T., FURUKAWA, H. & NABESHIMA, T. (1995). Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats tested with subacute phenycyclidine. Life Sci., 56, 531-543.
22. G-nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol., 221, 399-400.
23. KOMORI, Y., CHIANG, K.T. & FUKUTO, J.M. (1993). The effects of nonionic detergents on the activity and/or stability of rat brain nitric oxide synthase. Arch. Biochem. Biophys., 307, 311-315.
24. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
25. MURRAY, T.F. (1978). The effects of phencyclidine on operant behavior in the rat: biphasic effect and tolerance development. Life Sci., 22, 195-201.
26. NABESHIMA, T., FUKAYA, H., YAMAGUCHI, K., ISHIKAWA, K., FURUKAWA, H. & KAMEYAMA, T. (1987). Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. Eur. J. Pharmacol., 135, 23-33.
27. NABESHIMA, T., KAMEYAMA, T. & HO, I.K. (1982a). Mechanism of tolerance development to phencyclidine in relation to GABAergic neuronal and dispositional functions in mice. J. Pharmacobio-Dyn., 5, s-46.
28. NABESHIMA, T., SIVAM, S.P., TAI, C.Y. & HO, I.K. (1982b). Development of dispositional tolerance to phencyclidine by osmotic minipump in the mouse. J. Pharmacol. Methods, 7, 239-253.
29. NODA, Y., YAMADA, K., FURUKAWA, H. & NABESHIMA, T. (1995). Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice. Eur. J. Pharmacol., 256, 291-297.
30. O'DELL, T.J., HAWKINS, R.D., KANDEL, E.R. & ARANCIO, O. (1991). Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. U.S.A., 88, 11285-11289.
31. OHNO, M. & WATANABE, S. (1995). Nitric oxide synthase inhibitors block behavioural sensitization to methamphetamine in mice. Eur. J. Pharmacol., 275, 39-44.
32. OSAWA, Y. & DAVILA, J. (1993). Phencyclidine, a psychotomimetic agent and drug of abuse, is a suicide inhibitor of brain nitric oxide synthase. Biochem. Biophys. Res. Commun., 194, 1435-1439.
33. PALMER, R.M., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666.
34. PINCHASI, I., MAAYANI, S., EGOZI, Y. & SOKOLOVSKY, M. (1978a). On the interaction of drugs with the cholinergic nervous system II. Cross-tolerance between phencyclidine derivatives and cholinergic drugs. Psychopharmacology, 56, 37-40.
35. PINCHASI, I., MAAYANI, S. & SOKOLOVSKY, M. (1978b). On the interaction of drugs with the cholinergic nervous system. I. Tolerance to phencyclidine derivatives in mice. Psychopharmacology, 56, 27-36.
36. PUDIAK, C.M. & BOZATH, M.A. (1993). L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci., 53, 1517-1524.
37. RAUHALA, P., IDÄNPÄÄN-HEIKKILÄ, J.J., TUOMINEN, R.K. & MÄNNISTÖ, P.T. (1994). N-Nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur. J. Pharmacol., 258, 57-64.
38. SCHLEMMER, R.F., JACKSON, J.A., PRESTON, K.L., BEDERKA, J.P., GARVER, D.L. & DAVIS, J.M. (1978). Phencyclidine-induced stereotyped behavior in monkeys: antagonism by pimozide. Eur. J. Pharmacol., 52, 379-384.
39. SCHMIDT, W.J. (1986). Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology, 90, 123-130.
40. SCHUMAN, E.M. & MADISON, D.V. (1991). A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science, 254, 1503-1506.
41. SMITH, R.C., BIGGS, C.A., LEELAVATHI, D.E. & ALTSHULER, H.L. (1978). Behavioral effect of acute and chronic phencyclidine in rat. Neurosci. Abstr., 4, 503.
42. SONDERS, M.S., KEANA, J.F.W. & WEBER, E. (1988). Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Trends Neurosci., 11, 37-40.
43. STEINPREIS, R.E. & SALAMONE, J.D. (1993). The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain. Res., 612, 263-270.
44. STURGEON, R.D., FESSLER, R.G., LONDON, S.F. & MELZER, H.Y. (1982). Behavioral effect of chronic phencyclidine administration in rats. Psychopharmacology, 76, 52-56.
45. VINCENT, S.R. & KIMURA, H. (1992). Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience, 46, 755-784.
46. WOOLVERTON, W.L. & BALSTER, R.L. (1979). Tolerance to the behavioral effects of phencyclidine: the importance of behavioral and pharmacological variables. Psychopharmacology, 64, 19-24.
47. XU, X. & DOMINO, E.F. (1994). Phencyclidine-induced behavioral sensitization. Pharmacol. Biochem. Behav., 47, 603-608.
48. YAMADA, K., NODA, Y., HASEGAWA, T. & NABESHIMA, T. (1994). Effects of the inhibition of nitric oxide synthase on learning and memory in rats. Neurosci. Res. Abstr. suppl. 19, S248.